StockData
Amgen Inc logo

Amgen Inc (AMGN) stock

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3026% above fair value
$457.93−4.39 (-0.95%)

Close on Nov 17, 2026Market cap $247.57BP/E 26.5Yield 2.11%

Amgen gross margin

Gross margin is gross profit as a percentage of revenue.

Amgen's gross margin for the twelve months ending Sep 30, 2026 was 70.9%. For fiscal 2025 it was 67.2%, against 61.5% the year before. The highest annual figure on record is 82.7% in fiscal 2018.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202567.2%+5.7
FY2024Dec 31, 202461.5%−8.5
FY2023Dec 31, 202370.0%−5.6
FY2022Dec 31, 202275.7%+0.5
FY2021Dec 31, 202175.2%−0.6
FY2020Dec 31, 202075.8%−5.6
FY2019Dec 31, 201981.4%−1.4
FY2018Dec 31, 201882.7%+0.5
FY2017Dec 31, 201782.2%+0.3
FY2016Dec 31, 201681.9%+1.4
FY2015Dec 31, 201580.5%+2.5
FY2014Dec 31, 201478.0%−4.1
FY2013Dec 31, 201382.1%+0.6
FY2012Dec 31, 201281.5%−1.1
FY2011Dec 31, 201182.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202673.1%+5.4
Q2 FY2026Jun 30, 202672.0%+4.8
Q1 FY2026Mar 31, 202668.2%+4.6
Q4 FY2025Dec 31, 202569.8%+4.1
Q3 FY2025Sep 30, 202567.8%+6.7
Q2 FY2025Jun 30, 202567.2%+5.8
Q1 FY2025Mar 31, 202563.6%+6.5
Q4 FY2024Dec 31, 202465.7%+3.7
Q3 FY2024Sep 30, 202461.1%−12.8
Q2 FY2024Jun 30, 202461.4%−12.6
Q1 FY2024Mar 31, 202457.0%−14.8
Q4 FY2023Dec 31, 202362.0%−12.4
Q3 FY2023Sep 30, 202373.8%−2.3
Q2 FY2023Jun 30, 202374.0%−3.1
Q1 FY2023Mar 31, 202371.8%−3.1
Q4 FY2022Dec 31, 202274.5%−0.4
Q3 FY2022Sep 30, 202276.1%+1.4
Q2 FY2022Jun 30, 202277.1%+5.7
Q1 FY2022Mar 31, 202275.0%+4.2
Q4 FY2021Dec 31, 202174.9%+3.7
Q1 FY2021Mar 31, 202174.8%+3.6
Q4 FY2020Dec 31, 202071.4%−6.3
Q3 FY2020Sep 30, 202070.7%−5.4
Q2 FY2020Jun 30, 202071.2%−7.5
Q1 FY2020Mar 31, 202071.1%−4.7
Q2 FY2019Jun 30, 201977.7%+0.9
Q1 FY2019Mar 31, 201976.1%−3.1
Q4 FY2018Dec 31, 201878.7%−2.3
Q3 FY2018Sep 30, 201875.8%−1.5
Q2 FY2018Jun 30, 201876.8%−1.5
Q1 FY2018Mar 31, 201879.2%+2.3
Q4 FY2017Dec 31, 201781.0%−0.2
Q3 FY2017Sep 30, 201777.3%−4.1
Q2 FY2017Jun 30, 201778.3%−2.5
Q1 FY2017Mar 31, 201776.9%–
Q4 FY2016Dec 31, 201681.2%–
Q3 FY2016Sep 30, 201681.4%–
Q2 FY2016Jun 30, 201680.8%–

More Amgen figures

See a number that looks wrong?